BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33065626)

  • 1. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
    Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
    Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
    Jia G; Dong A; Cheng C; Zuo C
    Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer.
    Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A
    Clin Nucl Med; 2019 Dec; 44(12):e629-e633. PubMed ID: 31689286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemangioma of the Ilium Simulating Bone Metastasis on 18 F-PSMA-1007 PET/CT.
    Dong A; Nian S; Bai Y; Zuo C
    Clin Nucl Med; 2024 Jun; 49(6):e304-e306. PubMed ID: 38377381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic Hemangioma as a Potential Pitfall on PSMA-Targeted 18F-DCFPyL PET/CT.
    Chaussé G; Laufer J; Abikhzer G; Probst S
    Clin Nucl Med; 2019 Mar; 44(3):255-256. PubMed ID: 30589670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopsy-Proven Diffuse Mediastinal Prostate Cancer Metastases Negative on 18F-Fluorocholine, Diagnosed on 68Ga-PSMA and 18F-PSMA PET/CT.
    Chaussé G; Niazi T; Abikhzer GS; Probst SM
    Clin Nucl Med; 2017 Oct; 42(10):801-802. PubMed ID: 28719448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental Detection of Splenic Hemangioma on 68Ga-PSMA PET/CT.
    Sheng K; Le K; Bui C; Mansberg R
    Clin Nucl Med; 2019 Oct; 44(10):821-823. PubMed ID: 31162264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection Efficacy of
    Giesel FL; Knorr K; Spohn F; Will L; Maurer T; Flechsig P; Neels O; Schiller K; Amaral H; Weber WA; Haberkorn U; Schwaiger M; Kratochwil C; Choyke P; Kramer V; Kopka K; Eiber M
    J Nucl Med; 2019 Mar; 60(3):362-368. PubMed ID: 30042163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental Detection of Synchronous Benign Hepatic and Splenic Hemangiomas on 18 F-PSMA PET/CT.
    Alsaleh MH; Alkhars AS; Albensaad M; Alsharif A
    Clin Nucl Med; 2024 Jun; 49(6):e298-e300. PubMed ID: 38537220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraosseous Extension of Aggressive Vertebral Hemangioma as a Potential Pitfall on 68Ga-PSMA PET/CT.
    Probst S; Bladou F; Abikhzer G
    Clin Nucl Med; 2017 Aug; 42(8):624-625. PubMed ID: 28632693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorocholine PET/CT Finding of a Vertebral Hemangioma.
    Savelli G; Perotti V; Rosso E; Pizzocaro C; Magnaldi S
    Clin Nucl Med; 2016 Aug; 41(8):e390-1. PubMed ID: 27124683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of
    Gauthé M; Belissant O; Girard A; Zhang Yin J; Ohnona J; Cottereau AS; Nataf V; Balogova S; Pontvert D; Lebret T; Guillonneau B; Cussenot O; Talbot JN
    Prog Urol; 2017; 27(8-9):474-481. PubMed ID: 28576423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraindividual Comparison of
    Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
    J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
    Panagiotidis E; Paschali A; Giannoula E; Chatzipavlidou V
    Clin Nucl Med; 2019 Jan; 44(1):e46-e48. PubMed ID: 30371591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical Recurrence of Prostate Cancer: Initial Results with [
    Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
    Witkowska-Patena E; Giżewska A; Miśko J; Dziuk M
    Clin Nucl Med; 2019 Jun; 44(6):e401-e403. PubMed ID: 30932984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.
    Marafi F; Sasikumar A; Fathallah W; Esmail A
    Clin Nucl Med; 2020 Jan; 45(1):e61-e62. PubMed ID: 31162269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
    Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
    J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?
    Imperiale A; Cabral JF; Rust E; Flores-Turk G; Renard C; Hubele F; Detour J; Lang H; Gangi A; Namer IJ
    Clin Nucl Med; 2013 Feb; 38(2):e83-4. PubMed ID: 23334144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.